This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Humira
  • /
  • Safety and Efficacy of Humira (Adalimumab) for Hid...
Clinical trial

Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study) (SHARPS)

Read time: 2 mins
Last updated:30th Jun 2016
Identifier: NCT02808975
The objective of this study is to assess the safety and efficacy of adalimumab prior to surgery in subjects with moderate to severe Hidradenitis Suppurativa (HS) who are surgical candidates.
Category Value
Date last updated at source 2017-01-24
Study type(s) Interventional
Expected enrolment 200
Study start date 2016-07-01
Estimated primary completion date 2020-02-01

View full details